{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:08:44Z","timestamp":1787242124298,"version":"build-2736575974"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematol Oncol"],"DOI":"10.1186\/s13045-025-01772-5","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T02:24:24Z","timestamp":1767925464000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Clinical validation of UroCAD test for upper tract urothelial carcinoma detection: results from a prospective multi-center study"],"prefix":"10.1186","volume":"19","author":[{"given":"Guoliang","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuxiong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanliang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahua","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,9]]},"reference":[{"key":"1772_CR1","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.eururo.2023.03.013","volume":"84","author":"M Roupr\u00eat","year":"2023","unstructured":"Roupr\u00eat M, Seisen T, Birtle AJ, Capoun O, Comp\u00e9rat EM, Dominguez-Escrig JL, et al. European association of urology guidelines on upper urinary tract urothelial carcinoma: 2023 update. Eur Urol. 2023;84:49\u201364. https:\/\/doi.org\/10.1016\/j.eururo.2023.03.013.","journal-title":"Eur Urol"},{"key":"1772_CR2","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.eururo.2017.05.048","volume":"72","author":"TJ Moss","year":"2017","unstructured":"Moss TJ, Qi Y, Xi L, Peng B, Kim T-B, Ezzedine NE, et al. Comprehensive genomic characterization of upper tract urothelial carcinoma. Eur Urol. 2017;72:641\u20139. https:\/\/doi.org\/10.1016\/j.eururo.2017.05.048.","journal-title":"Eur Urol"},{"key":"1772_CR3","doi-asserted-by":"publisher","DOI":"10.1148\/rg.240056","volume":"44","author":"H Nakai","year":"2024","unstructured":"Nakai H, Takahashi H, Wellnitz CV, Stanton ML, Takahashi N, Kawashima A. Imaging of upper tract urothelial carcinoma. Radiographics. 2024;44:e240056. https:\/\/doi.org\/10.1148\/rg.240056.","journal-title":"Radiographics"},{"key":"1772_CR4","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.eururo.2023.09.017","volume":"85","author":"HL Huelster","year":"2024","unstructured":"Huelster HL, Gould B, Schiftan EA, Camperlengo L, Davaro F, Rose KM, et al. Novel use of circulating tumor DNA to identify muscle-invasive and non-organ-confined upper tract urothelial carcinoma. Eur Urol. 2024;85:283\u201392. https:\/\/doi.org\/10.1016\/j.eururo.2023.09.017.","journal-title":"Eur Urol"},{"key":"1772_CR5","doi-asserted-by":"publisher","first-page":"5646","DOI":"10.1158\/1078-0432.CCR-20-0401","volume":"26","author":"S Zeng","year":"2020","unstructured":"Zeng S, Ying Y, Xing N, Wang B, Qian Z, Zhou Z, et al. Noninvasive detection of urothelial carcinoma by cost-effective low-coverage whole-genome sequencing from urine-exfoliated cell DNA. Clin Cancer Res. 2020;26:5646\u201354. https:\/\/doi.org\/10.1158\/1078-0432.CCR-20-0401.","journal-title":"Clin Cancer Res"},{"key":"1772_CR6","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/j.euf.2020.08.001","volume":"7","author":"A Necchi","year":"2021","unstructured":"Necchi A, Madison R, Pal SK, Ross JS, Agarwal N, Sonpavde G, et al. Comprehensive genomic profiling of upper-tract and bladder urothelial carcinoma. Eur Urol Focus. 2021;7:1339\u201346. https:\/\/doi.org\/10.1016\/j.euf.2020.08.001.","journal-title":"Eur Urol Focus"},{"key":"1772_CR7","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1097\/JS9.0000000000001904","volume":"111","author":"J Ye","year":"2025","unstructured":"Ye J, Wang X, Liao X, Chen Y, Chen Z, Wang Q, et al. DNA methylation urine test in the diagnosis of upper tract urothelial carcinoma: a systematic review and meta-analysis. Int J Surg. 2025;111:1255\u201364. https:\/\/doi.org\/10.1097\/JS9.0000000000001904.","journal-title":"Int J Surg"},{"key":"1772_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14143537","volume":"14","author":"W Ouyang","year":"2022","unstructured":"Ouyang W, Luo L, Zhang J, Xu R, Lu Q, Xu Z, et al. Urine cellular DNA point mutation and methylation for identifying upper tract urinary carcinoma. Cancers (Basel). 2022;14:3537. https:\/\/doi.org\/10.3390\/cancers14143537.","journal-title":"Cancers (Basel)"},{"key":"1772_CR9","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1016\/j.euo.2024.03.005","volume":"7","author":"H Zhang","year":"2024","unstructured":"Zhang H, Xu Y, Wang K, Zheng C, Li Y, Gong H, et al. Large-scale prospective validation study of a multiplex RNA urine test for noninvasive detection of upper tract urothelial carcinoma. Eur Urol Oncol. 2024;7:1384\u201393. https:\/\/doi.org\/10.1016\/j.euo.2024.03.005.","journal-title":"Eur Urol Oncol"},{"key":"1772_CR10","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/s41577-021-00524-z","volume":"21","author":"A Decout","year":"2021","unstructured":"Decout A, Katz JD, Venkatraman S, Ablasser A. The cGAS-STING pathway as a therapeutic target in inflammatory diseases. Nat Rev Immunol. 2021;21:548\u201369. https:\/\/doi.org\/10.1038\/s41577-021-00524-z.","journal-title":"Nat Rev Immunol"},{"key":"1772_CR11","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1038\/s41586-023-06464-z","volume":"620","author":"J Li","year":"2023","unstructured":"Li J, Hubisz MJ, Earlie EM, Duran MA, Hong C, Varela AA, et al. Non-cell-autonomous cancer progression from chromosomal instability. Nature. 2023;620:1080\u20138. https:\/\/doi.org\/10.1038\/s41586-023-06464-z.","journal-title":"Nature"}],"container-title":["Journal of Hematology & Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-025-01772-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13045-025-01772-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-025-01772-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T02:24:25Z","timestamp":1767925465000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13045-025-01772-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":11,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1772"],"URL":"https:\/\/doi.org\/10.1186\/s13045-025-01772-5","relation":{},"ISSN":["1756-8722"],"issn-type":[{"value":"1756-8722","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,9]]},"assertion":[{"value":"9 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent has been obtained from the patient or an authorized guardian for publication and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal on request. And ethical approval was granted by the Ethics Committee of Changhai Hospital (No. CHEC2023-001) and Renji Hospital Ethics Committee (No. 2023\u2013030-A).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have reviewed and approved the manuscript for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All authors have no declarations to make regarding the use of generative AI and AI-assisted technologies in the writing process.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of Generative AI and AI-assisted technologies in the writing process"}}],"article-number":"8"}}